Bioprocessing Application Notes & Case Studies

  1. UPLC-MS/MS Determination Of GLP-1 Analogue 7/17/2025

    Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.

  2. Quantification Of Semaglutide With A Reliable Analytical Method 7/17/2025

    Explore a validated LC-MS/MS method for precise Semaglutide quantification in plasma, which features enhanced sensitivity, peak definition, and reproducibility using innovative technologies.

  3. Developing A Quantitative Surrogate Peptide Assay 7/17/2025

    Discover a streamlined LC-MS/MS workflow for Fc-containing therapeutics like dulaglutide to enable precise quantification with LLOQ as low as 1 ng/mL through automated, efficient assay development.

  4. Development Of An Effective LC-MS/MS Cleaning Validation Method 7/17/2025

    Gain insight into a robust LC-MS/MS method for quantifying therapeutic peptides that supports contamination control and cleaning validation to ensure product safety and integrity.

  5. Bioanalytical Quantification Of A Biotherapeutic Peptide 7/17/2025

    Discover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.

  6. Optimized Urine Liquid Biopsy Workflow 7/14/2025

    Urine-derived cell-free DNA is revolutionizing liquid biopsy research to offer a non-invasive, accessible tool for early disease detection, monitoring, and comprehensive diagnostics across oncology.

  7. Liquid Biopsy-Based Detection Of PIK3CA Mutations From cfDNA 7/14/2025

    Discover how ultra-sensitive digital PCR workflows use an innovative system to enable precise detection of rare PIK3CA mutations in cfDNA and advance personalized cancer treatment.

  8. Detect Ultra-Rare Variants In cfDNA From Liquid Biopsy Samples 7/14/2025

    Liquid biopsy, powered by next-generation sequencing, is transforming precision oncology to offer real-time, non-invasive insights into tumor genetics, which revolutionizes how we monitor and manage cancer.

  9. Quantifying Lentiviral Physical Titer 7/14/2025

    Streamline lentiviral vector analytics with our direct RT-dPCR method. Achieve precise, reproducible results to accelerate safe, effective gene therapies with enhanced quality control.

  10. Elevating Downstream Process Development With Real-Time Data Monitoring 7/11/2025

    Learn how real-time monitoring with PAT enhances process control, shortens development timelines, and supports the shift toward continuous manufacturing in biopharmaceutical production.